Eli Lilly and Company-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2015

  1. Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor‑β receptor I kinase inhibitor LY2157299 monohydrate

    Oncology Letters, Vol. 9, Núm. 6, pp. 2442-2448